Casla Partners Announces 2018 Fund Launch

SAN JUAN, PR – Casla Partners LLC (“Casla”) enters 2018 intending to raise its latest fund. Casla completed two transactions at the end of December including an investment in CPAP cleaning device company, SoClean Inc., as well as the sale of Alternative Biomedical Solutions, LLC (“ABS”), an ISO-certified leading supplier of high-performance mass spectrometry, toxicology, and chemistry measurement systems.

“We are excited to have closed out the year with strong momentum. We intend to build on that as we launch our latest fund.” said Samuel Hines, Managing Partner of Casla. Commenting on the ABS transaction, “Over the course of our partnership with ABS, the company has been transformed into a leading player in the toxicology sector. The Company’s impressive accomplishments under our ownership are representative of the value we look to build in our portfolio companies.” said Jared Rochwerg, a Casla Partner.

On the sale of ABS, Lazard Middle Market LLC acted as exclusive financial advisor, Moss Adams LLP as transaction advisor, and Goodwin Procter LLP as legal counsel to ABS.

About Casla Partners, LLC
Casla Partners is a Puerto Rico based investment firm focused on private equity and debt investments primarily in North American middle market companies. The firm seeks to create long-term value for its investors and generate superior risk adjusted returns by building sustainable success for its portfolio companies through a disciplined approach to positive change alongside proven management teams.

GET IN TOUCH
Investor Relations
Casla Partners LLC
646.873.7655
http://www.caslapartners.com

Release ID: 260077